During the past decade, Denver Neurological Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Denver Neurological Research" #1 sponsor was "Allergan" with 2 trials, followed by "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Denver Neurological Research" are "Migraine, With or Without Aura" (2 trials), "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials), "Lewy Body Dementia" (1 trials), "Migraine" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Denver Neurological Research" in a lesser frequency.

Most popular intervention types in "Denver Neurological Research" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Placebo-matching Ubrogepant" (2 trials), "Ubrogepant" (2 trials), "AVP-786-18" (1 trials) and "AVP-786-28" (1 trials). Other intervention names were less common.

The vast majority of trials in "Denver Neurological Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Denver Neurological Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Denver Neurological Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Denver Neurological Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".